Neurology

The Parkinson’s Foundation launched first-ever Nurse Fellowship program

The Parkinson’s Foundation recently announced the launch of its new Parkinson’s Nurse Fellowship program in the U.S. The fellowship award will offer support up to $95,000 “in salary, fringe benefits, malpractice insurance, research allowance, and...

Legalization of marijuana and schizophrenia

The legalization of marijuana for medicinal and recreational purposes is a hot topic in many states. As a mother and healthcare professional, I feel it is imperative that society be educated about the danger...

Managing carotid stenosis to prevent stroke

Watch for warning signs to reduce risk. Takeaways: Approximately 87% of all strokes are ischemic, with 30% directly attributed to atherosclerosis of the internal carotid artery. Within the first 3 months after a transient ischemic...

Johns Hopkins Center for Psychedelic Research

In early September 2019, Johns Hopkins opened its new Center for Psychedelic and Consciousness Research, which explores the use of psychedelics on brain function, memory, and the brain’s biology. The center explores the use of...

Cystocerebral syndrome

Rapid recognition leads to a quick reversal. Takeaways: Assess the full medical history of patients on admission, including bowel and bladder issues to reduce risk of delirium. Note that conditions other than the primary diagnosis...

This Month is National Alzheimer’s Disease Awareness Month!

To honor National Alzheimer’s Disease Awareness Month, I would like to highlight a feature of the disease that’s of special interest to me as a linguist: language function. As someone obsessed with language and language’s...

A potential link in high salt diets and cognitive decline

A new study from Nature highlights a potential link in high-salt diets and Alzheimer’s disease. The study examined salt-rich diets in mice, which led to “cognitive dysfunction associated with nitric oxide deficit in cerebral endothelial...

Emerging treatment for early Alzheimer’s disease

Biogen announced that it will pursue the U.S. Food and Drug Administration (FDA)’s regulatory approval process for its drug aducanumab to treat Alzheimer’s disease. The decision was based on findings from the phase 4 EMERGE...

Lessons to be learned through aphasia

In recognition of World Stroke Day, I want to share some lessons I learned during a previous lifetime when I worked alongside people with aphasia (PWA) in an aphasia research lab. After I graduated from...

Longer estrogen exposure improves cognitive function

Based on a new study, postmenopausal women may see improved cognitive function with endogenous estrogen exposure (EEE). The new study from The Journal of North American Menopause Society (NAMS) examined a sample of 2,114 postmenopausal...

Acute flaccid myelitis: Questions and possible answers

By Julie Cullen, Managing Editor, American Nurse Today Researchers are working hard to answer several questions about acute flaccid myelitis (AFM). Some recent information seems to be pointing the finger at enterovirus (specifically EV-D68 and...

FDA approves new treatment for migraine

On October 11, 2019, the Food and Drug Administration (FDA) announced a new acute, short-term treatment for patients with migraine. Eli Lilly’s Reyvow (lasmiditan) tablets have been approved for patients suffering from migraines, who may...

Seizure emergencies

Quick action guides treatment. Takeaways: Status epilepticus is a seizure that last 5 minutes or more or repetitive seizures with no recovery between them. Status epilepticus is a medical emergency requiring prompt action. The maximum...